BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12946641)

  • 1. An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors.
    Cacace A; Banks M; Spicer T; Civoli F; Watson J
    Drug Discov Today; 2003 Sep; 8(17):785-92. PubMed ID: 12946641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM; Bosse R; Reisine T
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative drug discovery approaches for orphan GPCRs.
    Levoye A; Jockers R
    Drug Discov Today; 2008 Jan; 13(1-2):52-8. PubMed ID: 18190864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of signal transduction pathways used by orphan g protein-coupled receptors.
    Bresnick JN; Skynner HA; Chapman KL; Jack AD; Zamiara E; Negulescu P; Beaumont K; Patel S; McAllister G
    Assay Drug Dev Technol; 2003 Apr; 1(2):239-49. PubMed ID: 15090189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying ligands at orphan GPCRs: current status using structure-based approaches.
    Ngo T; Kufareva I; Coleman JLj; Graham RM; Abagyan R; Smith NJ
    Br J Pharmacol; 2016 Oct; 173(20):2934-51. PubMed ID: 26837045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using silico methods predicting ligands for orphan GPCRs.
    Jiang Z; Zhou Y
    Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
    Morfa CJ; Bassoni D; Szabo A; McAnally D; Sharir H; Hood BL; Vasile S; Wehrman T; Lamerdin J; Smith LH
    Assay Drug Dev Technol; 2018 Oct; 16(7):384-396. PubMed ID: 30251873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan G-protein-coupled receptors: the next generation of drug targets?
    Wilson S; Bergsma DJ; Chambers JK; Muir AI; Fantom KG; Ellis C; Murdock PR; Herrity NC; Stadel JM
    Br J Pharmacol; 1998 Dec; 125(7):1387-92. PubMed ID: 9884064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
    Suga H; Haga T
    Neurochem Int; 2007; 51(2-4):140-64. PubMed ID: 17659814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers.
    Levoye A; Dam J; Ayoub MA; Guillaume JL; Jockers R
    EMBO Rep; 2006 Nov; 7(11):1094-8. PubMed ID: 17077864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling and Deorphanization of Orphan GPCRs.
    Diaz C; Angelloz-Nicoud P; Pihan E
    Methods Mol Biol; 2018; 1705():413-429. PubMed ID: 29188576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second annual GPCRs: from orphan to blockbuster.
    Gilchrist A
    Expert Opin Ther Targets; 2004 Oct; 8(5):495-8. PubMed ID: 15469398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphan GPCRs and methods for identifying their ligands.
    Yoshida M; Miyazato M; Kangawa K
    Methods Enzymol; 2012; 514():33-44. PubMed ID: 22975044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CellCard System: a novel approach to assessing compound selectivity for lead prioritization of G protein-coupled receptors.
    Beske O; Goldbard S; Turpin P
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):293-9. PubMed ID: 16101005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.